1 / 58

VENTILATION FOR THE SURGICAL RESIDENT

VENTILATION FOR THE SURGICAL RESIDENT. POS review lecture 2008-2009 Heather Whittingham. OBJECTIVES. Respiratory physiology oxygen delivery abnormalities of gas exchange review of lung volumes chest wall and respiratory mechanics Mechanical Ventilation indications nomenclature

reya
Download Presentation

VENTILATION FOR THE SURGICAL RESIDENT

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. VENTILATION FOR THE SURGICAL RESIDENT POS review lecture 2008-2009 Heather Whittingham

  2. OBJECTIVES • Respiratory physiology • oxygen delivery • abnormalities of gas exchange • review of lung volumes • chest wall and respiratory mechanics • Mechanical Ventilation • indications • nomenclature • ventilation modes: invasive and non-invasive • special circumstances: ARDS, refractory hypoxemia and BPF • complications: High pressures, VILI, Auto-PEEP, VAP • weaning

  3. RESPIRATORY PHYSIOLOGY REVIEW

  4. OXYGEN DELIVERY • oxygen is carried in the blood in two forms: • bound to Hb (SpO2) * • dissolved in plasma (PaO2) • oxygen content (CaO2) is the sum of both: • oxygen delivery is a product of both the arterial O2 content and cardiac output harder to unload O2 [Hb] x SpO2 x (1.36) + easier to unload O2 (PaO2) x (0.003)

  5. OXYGENATION • Hypoxia is a state of tissue oxygen deprivation • anaerobic metabolism  lactic acidosis • can lead to cellular, tissue and organ death • Hypoxia can result from: • low PaO2 • anemia or abnormal Hb • low cardiac output states/ impaired perfusion • inability to utilize O2 (eg. cyanide) • Hypoxemia refers to low PaO2 in the blood

  6. ABNORMAL GAS EXCHANGE • Efficiency of gas exchange: the a-a gradient • P(A-a)O2 = PAO2 – PaO2 • PAO2 = [713 x FiO2] – [1.25 x PaCO2] • cumbersome, normal values not known for supplemental O2 • Often use P/F ratio instead: PaO2/FiO2 • normal on FiO2 0.21 is 450-500 range • tells us nothing about alveolar ventilation (PCO2) • will be dependent on level of PEEP/ CPAP

  7. ABNORMAL GAS EXCHANGE

  8. INTRAPULMONARY SHUNT

  9. VENTILATION • Ventilation refers to CO2 clearance • Alveolar ventilation • air that meets perfused alveoli and participates in gas exchange • Dead space ventilation • air doesn’t contact perfused alveoli to participate in gas exchange • anatomic+ alveolar + equipment • “wasted” ventilation • Minute Ventilation (MV) • RR x VT • total gas (L/min) of ventilation • normal 6-8 L/min

  10. ABNORMAL GAS EXCHANGE • rarely causes hypercapnia in absence of other ventilatory defect HYPERCAPNIA • Mechanisms: • Increased CO2 production • malignant hyperthermia • thyroid storm • Decreased CO2 clearance • low minute ventilation (RR x VT) • high dead space ventilation • low respiratory drive • CNS depression • drugs • OHS/ CSA • respiratory mechanical failure • fatigue • neuromuscular disease • chest wall abnormality • underlying lung pathology • COPD • ILD • pulmonary embolism • pulmonary vascular disease

  11. LUNG VOLUMES • TLC: amount of gas in lungs after maximal inspiration • RV: amount of gas in lungs after maximal expiration • VC: volume of gas expired going from TLC to RV • FRC: volume of gas in lungs at the resting state (end-expiration) • TV: amount of gas inhaled in a normal inspiration

  12. PULMONARY COMPLIANCE • Defined as the ability of the lung to stretch (change in volume) relative to an applied pressure • Factors affecting compliance: • lung volume (overdistention vs. atelectasis) • interstitial pathology (CHF, ILD) • alveolar pathology (pneumonia, CHF, blood) • pleural pathology (pleural effusion, fibrosis) • chest wall mechanics • diaphragm mobility • chest wall deformities • abdominal pressures

  13. RESPIRATORY FAILURE

  14. RESPIRATORY FAILURE • Acute respiratory failure: “any impairment of O2 uptake or CO2 elimination or both that is severe enough to be a threat to life” • The signs and symptoms of respiratory failure are non-specific and often non-respiratory • reflect end-organ dysfunction of neurologic and cardiovascular systems RESPIRATORY FAILURE HYPOXEMIC HYPERCAPNIC Won’t breathe Can’t breathe

  15. RESPIRATORY FAILURE • Clinical signs and Symptoms • hypoxia is relatively easily identified on clinical examination • hypercapnia can be more subtle in its presentation • may not be in respiratory distress (central failure) Respiratory General Cardiovascular Neurologic • tachypnea • dyspnea • diaphoresis • central cyanosis (late) • restlessness • headache • confusion • delirium • tremor • asterixis • seizures • coma • tachycardia • dysrhythmias • hypertension • hypotension • wheeze • dyspnea • cough • accessory muscle use • abdominal paradox

  16. MECHANICAL VENTILATION

  17. MV: INDICATIONS • Hypoventilation • arterial pH more important than absolute pCO2 • can result from central or mechanical failure • respiratory acidosis with pH <7.25 and pCO2 >50 • Hypoxemia • hypoxemia refractory to conservative measures • pO2 < 60 with FiO2 >60% • Respiratory Fatigue • excessive work of breathing suggestive of impending respiratory failure • Airway Protection

  18. MV: INDICATIONS • most absolute criteria for initiation of mechanical ventilation are arbitrary and reflect a line drawn in the sand • fail to account for a spectrum of disease • a PaO2 of 61 is acceptable and 59 is not? • chronic vs acute derangements • fail to account for co-morbid disease management • precise control of PaCO2 in a patient with a head injury • assisted hyperventilation to compensate for a metabolic acidosis • airway maintenance with nasal airway or surgical airway “the patient looked like they need to be placed on a ventilator”

  19. NOMENCLATURE • A “mode” is a pattern of breaths delivered by the ventilator • pressure support • pressure control • volume control • To understand the differences, must understand the “phases” of ventilation • expiratory: passive phase, PEEP applied • triggering: change from expiration to inspiration • inspiratory: assisted inspiratory flow • cycling: end of inspiration and change to expiration

  20. PHASES OF VENTILATION • Triggering: • patient triggered (flow, pressure) • machine triggered (time) • Inspiration-assisted • Cycling • time (PCV) • volume (VCV) • flow (PSV) • Expiration- passive C INSP B A EXP D

  21. VOLUME CONTROL (VCV) • Set tidal volume, cycles into exhalation when target volume has been reached; airway pressure dependent on lung compliance • guarantees a minimum minute ventilation (MV= RR x Vt) • useful for patients with a decreased respiratory drive • post-operative, head-injured, narcotic overdose • Variables: • Trigger: patient or machine controlled • Inspiratory phase: set inspiratory flow rate • Cycling: SET • Expiratory phase: set amount of PEEP • Alarms: high pressure (default into PCV and cycle), high RR

  22. PRESSURE CONTROL (PCV) • Inspiratory pressure and inspiratory time are set; tidal volume is dependent on lung compliance • allows for control of peak airway pressures (ARDS) • a longer inspiratory time can allow for better recruitment and oxygenation • Variables: • Trigger: patient or machine controlled • Inspiratory phase: SET- target pressure, generated quickly and maintained throughout; high initial flow rate • Cycling: time • Expiratory phase: set amount of PEEP • Alarms: high and low tidal volumes, high RR

  23. PRESSURE SUPPORT (PSV) • Spontaneous mode of ventilation; patient generates each breath and a set amount of pressure is delivered with each breath to ‘support’ the breath • comfortable: determine own RR, inspiratory flow and time • Vt depends on level of pressure support set, lung compliance and patient effort • Variables: • Trigger: patient controlled; must initiate breath • Inspiratory phase: SET support pressure • Cycling: flow cycled (when falls to ~25% of peak) • Expiratory phase: set amount of PEEP • Alarms: apnea and high RR

  24. NOMENCLATURE • CMV (Controlled Mechanical Ventilation) • minute ventilation entirely determined by set RR and Vt • patient efforts do not contribute to minute ventilation • AC (Assist/Control) • combination of mandatory (set rate) and patient triggered breaths • patient triggered breaths deliver same Vt or pressure as mandatory breaths • SIMV (Synchronized Intermittent Mandatory Ventilation) • combination of mandatory and patient-triggered breaths • pure SIMV, patient not assisted on additional breaths • can combine SIMV with PSV, so additional breaths are supported

  25. NOMENCLATURE • Comparison of respiratory pattern using different modes:

  26. PEEP • Positive End-Expiratory Pressure (PEEP) • constant baseline pressure delivered throughout cycle • by convention: called CPAP if breathing spontaneously and PEEP if receiving positive pressure ventilation • 3-5cm H20 PEEP provided to all intubated patients to overcome the decrease in FRC caused by bypass of glottis • Advantages: • Improve oxygenation by preventing end-expiratory collapse of alveoli and help recruit new alveoli • may prevent barotrauma caused by repetitive opening and closing of alveoli • creates hydrostatic forces to fluid from alveoli into interstitium

  27. PEEP- COMPLICATIONS • Potential complications: • may overdistend alveoli: • causing barotrauma • can worsen oxygenation by increasing dead space • decreases venous return (high intrathoracic pressures) • decreasing cardiac output • increases RV afterload • can contribute to RV strain and/or failure associated with severe respiratory failure • lung heterogeneous • some areas may be getting too much, while others not enough

  28. PEEP- CONTRAINDICATIONS • Relative contraindications to high PEEP • circumstances where risk may outweigh benefit:

  29. NON-INVASIVE VENTILATION • The delivery of PPV without an ETT • avoids complications of intubation, including VAP • Two fundamental types: CPAP and bi-level or BiPAP • CPAP delivers continuous positive pressure throughout respiratory cycle • useful for hypoxemic respiratory failure • BiPAP delivers ‘pressure support’ during inspiration (IPAP), coupled with PEEP during expiration (EPAP) • useful for hypercapneic or combined respiratory failure

  30. NIV: INDICATIONS • Has been shown to decrease need for intubation and decrease morbidity & mortality in certain patients: • Acute cardiogenic pulmonary edema (ACPE) • COPD exacerbation • May decrease re-intubation rate after extubation in COPD • Fundamental requirements: • spontaneously breathing patient who can protect airway • potentially reversible condition • ability to improve within a few hours • cooperative patient • no hemodynamic instability, no cardiac ischemia

  31. NIV: CONTRAINDICATIONS • Hemodynamic instability or shock • Decreased LOC and inability to protect airway • Inadequate respiratory drive • High risk of aspiration (SBO, UGI bleed) • Facial trauma or craniofacial abnormality • Upper airway obstruction • Uncooperative patient • Inability to clear secretions or excessive secretions

  32. NIV: MONITORING • NIV has been successful if the patient’s work of breathing has decreased and blood gas abnormalities are starting to resolve • Clinical improvement is usually evident within the 1st hour • Biochemical improvement usually evident within 2-4 hours of initiation If ongoing evidence of respiratory failure despite NIV within a few hours of initiation… CONSIDER INTUBATION

  33. SPECIAL CIRCUMSTANCES

  34. ARDS • Definition: • bilateral pulmonary infiltrates • absence of LA hypertension • severe hypoxemia (PaO2/FiO2 ratio <200) • Heterogeneous lung involvement • dependent: atelectatic, consolidated • non-dependent: relatively preserved • Concept of the “baby lung” • high inflation pressures/ volumes used for hypoxemia can damage normal lung (volutrauma, barotrauma) • repetitive opening/closing of marginal areas causes additional trauma (atelectrauma)

  35. ARDS: VENTILATION • Important to understand principles of ARDS to minimize ventilator-induced lung injury • Lung protective ventilation (ARDSnet) • compared tidal volume of 12ml/kg (840) and plateau <50 cm H2O vs 6ml/kg (420) and plateau <30 cm H2O • stopped early for benefit • mortality 31 vs 39% (p=0.007) • more vent free days • Mild permissive hypercapneia ok • May require sedation to maintain

  36. REFRACTORY HYPOXIA • Some additional modes of ventilation can be tried for hypoxia refractory to conventional ventilation: • recruitment maneuvers • inverse ratio ventilation (I>E) • prone ventilation • airway pressure release ventilation (APRV) • high frequency oscillation ventilation (HFOV) • None to date have shown an increased mortality, but can improve oxygenation

  37. APR VENTILATION • APRV ventilates by time-cycled switching between two pressure levels (Phigh and Plow) • degree of ventilator support is determined by the duration of the two pressure levels and the tidal volume delivered • tidal volume determined by Δ P and respiratory compliance • permits spontaneous breathing in any phase • better ventilation of posterior, dependent lung regions after 24h • improves recruitment • lower sedation required • C/I if deep sedation needed, COPD?

  38. HFO VENTILATION • HFOV achieves gas transport by rapidly oscillating a small Vt (~anatomic dead space) achieving rapid gas mixing in the lung • gas transport occurs along partial-pressure gradients • oscillates around a constant high mean airway pressure (mPaw) to maintain alveolar recruitment, avoiding big Δ P • risk of barotrauma and hemodynamic compromise limilar to conventional ventilation • O2: mPaw and FiO2 • CO2: frequency and ΔP

  39. BRONCHOPLEURAL FISTULA • Presence of a persistent air-leak >24h after insertion of a CT is highly suggestive of a bronchopleural fistula • after exclusion of an external leak • Weaning from PPV entirely is optimal • When not possible, select strategy to minimize minute ventilation and intrathoracic pressure

  40. BPF- MANAGEMENT • Wean ventilatory support as much as tolerates • PSV may be preferable to full ventilation • limit mean airway pressure and number of high pressure breaths • avoid alkalosis; consider permissive hypercapnia • minimize PEEP (intrinsic and extrinsic); treat bronchospasm • Limit VT to 6-8 ml/kg • Minimize inspiratory time (keep I:E ratio low, use high flows) • Use lowest CT suction that maintains lung inflation • Explore positional differences that minimize leak

  41. BPF- MANAGEMENT • Consider specific or unconventional measures for physiologically significant leaks: • independent lung ventilation • endobronchial approach to sealing leak • surgical closure • Treat underlying cause of respiratory failure

  42. BPF in ARDS • Usually a measure of severity of underlying disease will -- -often doesn’t improve until ARDS improves • BPF nearly always improves without specific therapy • BPF usually not physiologically significant (<10%), even in presence of hypercapnia • Reducing the size of the leak has minimal effect on gas exchange • No specific measures have been shown to affect outcome • Patients almost never die of BPF… they die with BPF

  43. COMPLICATIONS OF VENTILATION

  44. HIGH AIRWAY PRESSURES • Decreased Compliance • pneumothorax • mainstem intubation • dynamic hyperinflation • CHF • ARDS • consolidation • pneumonectomy • pleural effusion • abdominal distention • chest wall deformity • Increased Resistance • bronchospasm • secretions • small ETT • mucosal edema • biting ETT

  45. VILI VENTILATOR-INDUCED LUNG INJURY • multiple recognized forms: • barotrauma: • high ventilation pressures result in global or regional overdistention  can result in alveolar rupture • may be gross (PTX, BPF, subcut emphysema) or microscopic • volutrauma/atelectrauma: • ventilation at low lung volumes causes repetitive opening and closing of alveoli • may lead to shear stress, disruption of surfactant and epithelium • biotrauma: • mechanical stretch or shear injury lead to inflammatory mediator release and cellular activation

  46. VILI • Prevention: • low VT ventilatory strategies • minimize peak and plateau pressures • PEEP for recruitment and minimize end-expiratory collapse • tolerate mild to moderate permissive hypercapnia to achieve above goals: • allowing PCO2 to rise into high 40’s to 50’s to reduce driving and plateau pressures • generally considered safe at low levels • contraindications: increased ICP, acute or chronic cardiac ischemia, severe PH, RV failure, uncorrected severe metabolic acidosis, TCA overdose, pregnancy

  47. AUTO-PEEP • aka: intrinsic PEEP or dynamic hyperinflation • Seen when a patient has failed to expire full VT and subsequent breaths delivered result in increasing hyperinflation

  48. AUTO-PEEP • Making the diagnosis: • inspection: continuous inward movement of chest until start of next breath • auscultation: persistence of breath sounds until start of next ventilator breath • failure to return to baseline on waveform before delivery of next breath “Auto-PEEP” “normal”

  49. AUTO-PEEP

  50. AUTO-PEEP: MANAGEMENT • Lengthen time for exhalation • slow controlled rate on ventilator • lengthen I:E ratio (shorten I time) • may require patient sedation if patient-driven • Treat bronchospasm • bronchodilators • corticosteroids if asthma or AECOPD • Match intrinsic PEEP to minimize gas trapping by dynamic collapse

More Related